TipRanks
Insulet (DE:GOV)
XETRA:GOV
Germany Market
GOV
Insulet
RESEARCH TOOLSreports

Insulet (GOV) Stock Forecast & Price Target

5 Followers
See the Price Targets and Ratings of:

GOV Analyst Ratings

Moderate Buy
18Ratings
Moderate Buy
9 Buy
9 Hold
0 Sell
Based on 18 analysts giving stock ratings to
Insulet
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

GOV Stock 12 Month Forecast

Average Price Target

€145.06
▲(18.56% Upside)
Based on 18 Wall Street analysts offering 12 month price targets for Insulet in the last 3 months. The average price target is €145.06 with a high forecast of €163.21 and a low forecast of €127.04. The average price target represents a 18.56% change from the last price of €122.35.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"126":"€126","289":"€289","166.75":"€166.8","207.5":"€207.5","248.25":"€248.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":163.20697225,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€163.21</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":145.05886105,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€145.06</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":127.0367784,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€127.04</span>\n  </div></div>","useHTML":true}}],"tickPositions":[126,166.75,207.5,248.25,289],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,128.25,130.9389978653846,133.62799573076924,136.31699359615385,139.00599146153846,141.6949893269231,144.3839871923077,147.0729850576923,149.7619829230769,152.45098078846155,155.13997865384616,157.82897651923076,160.5179743846154,{"y":163.20697225,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,128.25,129.54298931153846,130.83597862307693,132.1289679346154,133.42195724615385,134.71494655769231,136.00793586923078,137.3009251807692,138.59391449230768,139.88690380384614,141.1798931153846,142.47288242692306,143.76587173846153,{"y":145.05886105,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,128.25,128.15667526153845,128.06335052307693,127.97002578461539,127.87670104615384,127.78337630769231,127.69005156923077,127.59672683076923,127.5034020923077,127.41007735384616,127.31675261538462,127.22342787692308,127.13010313846154,{"y":127.0367784,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":288.5,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":259.8,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":267.3,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":267.2,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":242,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":217.2,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":209.8,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":178.5,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":146.1,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":127.1,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":140,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":143.3,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":128.25,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€163.21Average Price Target€145.06Lowest Price Target€127.04
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi Analyst forecast on DE:GOV
Joanne Wuensch
Citi
Citi
―
Hold
―
Reiterated
09/30/26
Analysts Offer Insights on NA Companies: Insulet (NASDAQ: PODD) and General Motors (NYSE: GM)
UBS Analyst forecast on DE:GOV
Patrick Wood
UBS
UBS
€132.33
Hold
8.16%
Upside
Assigned
08/12/26
Wall Street Analysts Are Neutral on Top Healthcare Picks
Evercore ISI Analyst forecast on DE:GOV
Daniel Markowitz CFA
Evercore ISI
Evercore ISI
€158.8
Buy
29.79%
Upside
Reiterated
08/06/26
Analysts Are Bullish on These Healthcare Stocks: Myomo (MYO), CVS Health (CVS)
Robert W. Baird Analyst forecast on DE:GOV
Jeff Johnson
Robert W. Baird
Robert W. Baird
€218.79→€154.38
Buy
26.18%
Upside
Reiterated
08/06/26
Insulet price target lowered to $175 from $248 at BairdInsulet price target lowered to $175 from $248 at Baird
Leerink Partners Analyst forecast on DE:GOV
Mike Kratky
Leerink Partners
Leerink Partners
€127.92
Hold
4.55%
Upside
Downgraded
08/06/26
Insulet downgraded to Market Perform from Outperform at LeerinkInsulet downgraded to Market Perform from Outperform at Leerink
Truist Financial Analyst forecast on DE:GOV
Richard Newitter
Truist Financial
Truist Financial
€185.26→€134.98
Hold
10.32%
Upside
Downgraded
08/06/26
Insulet downgraded to Hold from Buy at TruistInsulet downgraded to Hold from Buy at Truist
TD Cowen Analyst forecast on DE:GOV
Mathew Blackman
TD Cowen
TD Cowen
€259.37→€127.04
Hold
3.83%
Upside
Assigned
08/06/26
Analysts Offer Insights on Healthcare Companies: Insulet (NASDAQ: PODD), ImageneBio (NASDAQ: IMA) and InMode (NASDAQ: INMD)
Canaccord Genuity Analyst forecast on DE:GOV
William Plovanic
Canaccord Genuity
Canaccord Genuity
€219.67→€157.91
Buy
29.07%
Upside
Reiterated
08/06/26
Insulet price target lowered to $179 from $249 at CanaccordInsulet price target lowered to $179 from $249 at Canaccord
Stifel Nicolaus Analyst forecast on DE:GOV
Jonathan Block
Stifel Nicolaus
Stifel Nicolaus
€198.49→€158.8
Buy
29.79%
Upside
Assigned
08/06/26
Stifel Nicolaus Sticks to Its Buy Rating for Insulet (PODD)
Deutsche Bank Analyst forecast on DE:GOV
Kieran Ryan
Deutsche Bank
Deutsche Bank
€167.62→€158.8
Buy
29.79%
Upside
Reiterated
08/06/26
Insulet (PODD) Receives a Buy from Deutsche Bank
Bernstein Analyst forecast on DE:GOV
Lee Hambright
Bernstein
Bernstein
€176.44→€154.38
Buy
26.18%
Upside
Reiterated
08/06/26
Bernstein Remains a Buy on Insulet (PODD)
Benchmark Co. Analyst forecast on DE:GOV
Bruce Jackson
Benchmark Co.
Benchmark Co.
€220.55→€163.21
Buy
33.39%
Upside
Reiterated
08/06/26
Analysts Conflicted on These Healthcare Names: Aurora Cannabis (NASDAQ: ACB), Biodesix (NASDAQ: BDSX) and Insulet (NASDAQ: PODD)
BTIG Analyst forecast on DE:GOV
Marie Thibault
BTIG
BTIG
―
Hold
―
Downgraded
08/06/26
Insulet downgraded to Neutral from Buy at BTIGInsulet downgraded to Neutral from Buy at BTIG
William Blair Analyst forecast on DE:GOV
Steven Lichtman
William Blair
William Blair
―
Buy
―
Reiterated
08/05/26
Analysts' Top Healthcare Picks: Insulet (PODD), Entrada Therapeutics Inc (TRDA)
Oppenheimer Analyst forecast on DE:GOV
Suraj Kalia
Oppenheimer
Oppenheimer
―
Hold
―
Downgraded
08/05/26
Insulet downgraded to Perform from Outperform at OppenheimerInsulet downgraded to Perform from Outperform at Oppenheimer
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi Analyst forecast on DE:GOV
Joanne Wuensch
Citi
Citi
―
Hold
―
Reiterated
09/30/26
Analysts Offer Insights on NA Companies: Insulet (NASDAQ: PODD) and General Motors (NYSE: GM)
UBS Analyst forecast on DE:GOV
Patrick Wood
UBS
UBS
€132.33
Hold
8.16%
Upside
Assigned
08/12/26
Wall Street Analysts Are Neutral on Top Healthcare Picks
Evercore ISI Analyst forecast on DE:GOV
Daniel Markowitz CFA
Evercore ISI
Evercore ISI
€158.8
Buy
29.79%
Upside
Reiterated
08/06/26
Analysts Are Bullish on These Healthcare Stocks: Myomo (MYO), CVS Health (CVS)
Robert W. Baird Analyst forecast on DE:GOV
Jeff Johnson
Robert W. Baird
Robert W. Baird
€218.79→€154.38
Buy
26.18%
Upside
Reiterated
08/06/26
Insulet price target lowered to $175 from $248 at BairdInsulet price target lowered to $175 from $248 at Baird
Leerink Partners Analyst forecast on DE:GOV
Mike Kratky
Leerink Partners
Leerink Partners
€127.92
Hold
4.55%
Upside
Downgraded
08/06/26
Insulet downgraded to Market Perform from Outperform at LeerinkInsulet downgraded to Market Perform from Outperform at Leerink
Truist Financial Analyst forecast on DE:GOV
Richard Newitter
Truist Financial
Truist Financial
€185.26→€134.98
Hold
10.32%
Upside
Downgraded
08/06/26
Insulet downgraded to Hold from Buy at TruistInsulet downgraded to Hold from Buy at Truist
TD Cowen Analyst forecast on DE:GOV
Mathew Blackman
TD Cowen
TD Cowen
€259.37→€127.04
Hold
3.83%
Upside
Assigned
08/06/26
Analysts Offer Insights on Healthcare Companies: Insulet (NASDAQ: PODD), ImageneBio (NASDAQ: IMA) and InMode (NASDAQ: INMD)
Canaccord Genuity Analyst forecast on DE:GOV
William Plovanic
Canaccord Genuity
Canaccord Genuity
€219.67→€157.91
Buy
29.07%
Upside
Reiterated
08/06/26
Insulet price target lowered to $179 from $249 at CanaccordInsulet price target lowered to $179 from $249 at Canaccord
Stifel Nicolaus Analyst forecast on DE:GOV
Jonathan Block
Stifel Nicolaus
Stifel Nicolaus
€198.49→€158.8
Buy
29.79%
Upside
Assigned
08/06/26
Stifel Nicolaus Sticks to Its Buy Rating for Insulet (PODD)
Deutsche Bank Analyst forecast on DE:GOV
Kieran Ryan
Deutsche Bank
Deutsche Bank
€167.62→€158.8
Buy
29.79%
Upside
Reiterated
08/06/26
Insulet (PODD) Receives a Buy from Deutsche Bank
Bernstein Analyst forecast on DE:GOV
Lee Hambright
Bernstein
Bernstein
€176.44→€154.38
Buy
26.18%
Upside
Reiterated
08/06/26
Bernstein Remains a Buy on Insulet (PODD)
Benchmark Co. Analyst forecast on DE:GOV
Bruce Jackson
Benchmark Co.
Benchmark Co.
€220.55→€163.21
Buy
33.39%
Upside
Reiterated
08/06/26
Analysts Conflicted on These Healthcare Names: Aurora Cannabis (NASDAQ: ACB), Biodesix (NASDAQ: BDSX) and Insulet (NASDAQ: PODD)
BTIG Analyst forecast on DE:GOV
Marie Thibault
BTIG
BTIG
―
Hold
―
Downgraded
08/06/26
Insulet downgraded to Neutral from Buy at BTIGInsulet downgraded to Neutral from Buy at BTIG
William Blair Analyst forecast on DE:GOV
Steven Lichtman
William Blair
William Blair
―
Buy
―
Reiterated
08/05/26
Analysts' Top Healthcare Picks: Insulet (PODD), Entrada Therapeutics Inc (TRDA)
Oppenheimer Analyst forecast on DE:GOV
Suraj Kalia
Oppenheimer
Oppenheimer
―
Hold
―
Downgraded
08/05/26
Insulet downgraded to Perform from Outperform at OppenheimerInsulet downgraded to Perform from Outperform at Oppenheimer
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ONCBeOne Medicines
OVIDOvid Therapeutics
WSTWest Pharmaceutical Services
ZYMEZymeworks
SLDBSolid Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Insulet

3 Months
Matthew TaylorJefferies
Success Rate
16/19 ratings generated profit
84%
Average Return
+9.54%
Copying Matthew Taylor's trades and holding each position for 3 Months would result in 84.21% of your transactions generating a profit, with an average return of +9.54% per trade.
1 Year
Matthew TaylorJefferies
Success Rate
13/19 ratings generated profit
68%
Average Return
+16.60%
Copying Matthew Taylor's trades and holding each position for 1 Year would result in 68.42% of your transactions generating a profit, with an average return of +16.60% per trade.
2 Years
Jayson BedfordRaymond James
Success Rate
19/31 ratings generated profit
61%
Average Return
+37.90%
Copying Jayson Bedford's trades and holding each position for 2 Years would result in 61.29% of your transactions generating a profit, with an average return of +37.90% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GOV Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
20
20
16
3
1
Buy
15
21
21
19
12
Hold
5
5
5
13
14
Sell
2
2
2
0
0
Strong Sell
0
0
0
0
0
total
42
48
44
35
27
In the current month, GOV has received 13 Buy Ratings, 14 Hold Ratings, and 0 Sell Ratings. GOV average Analyst price target in the past 3 months is 145.06.
Each month's total comprises the sum of three months' worth of ratings.

GOV Financial Forecast

GOV Earnings Forecast

Next quarter’s earnings estimate for GOV is €1.41 with a range of €1.36 to €1.48. The previous quarter’s EPS was €1.48. GOV beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year GOV has Performed in-line its overall industry.
Next quarter’s earnings estimate for GOV is €1.41 with a range of €1.36 to €1.48. The previous quarter’s EPS was €1.48. GOV beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year GOV has Performed in-line its overall industry.

GOV Sales Forecast

Next quarter’s sales forecast for GOV is €741.27M with a range of €735.26M to €745.73M. The previous quarter’s sales results were €713.35M. GOV beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year GOV has Performed in-line its overall industry.
Next quarter’s sales forecast for GOV is €741.27M with a range of €735.26M to €745.73M. The previous quarter’s sales results were €713.35M. GOV beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year GOV has Performed in-line its overall industry.

GOV Stock Forecast FAQ

What is DE:GOV’s average 12-month price target, according to analysts?
Based on analyst ratings, Insulet’s 12-month average price target is 145.06.
    What is DE:GOV’s upside potential, based on the analysts’ average price target?
    Insulet has 18.56% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Insulet a Buy, Sell or Hold?
          Insulet has a consensus rating of Moderate Buy, which is based on 9 buy ratings, 9 hold ratings and 0 sell ratings.
            What is Insulet’s share price target?
            The average share price target for Insulet is 145.06. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €163.21 ,and the lowest forecast is €127.04. The average share price target represents 18.56% Increase from the current price of €122.35.
              What do analysts say about Insulet?
              Insulet’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 18 Wall Streets Analysts.
                How can I buy shares of Insulet?
                To buy shares of DE:GOV, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.